• Français
• Site Map
• Glossary
• Contact Us
• Home

• About DiagnoCure
  • Mission and History
  • Board of Directors
  • Management
  • Advisory Board
  • Intellectual Property
• Investors
  • Overview
  • Q&A
  • Financial Information
  • Press Releases
  • Strategy
  • Management
  • Presentations
  • Analysts
  • Corporate Governance
  • Investors Contact
• News and Events
  • Overview
  • Press Releases
  • Events
  • News Alerts
  • Media Room
• Products and Projects
  • Overview
  • Highlights on Cancer
  • Molecular Diagnostics
  • Prostate Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Bladder Cancer
  • Other R&D Projects
  • Useful Links
• Customer Service
• Career
  • A Career of Passion
  • Talent Wanted

Customer Service

DiagnoCure Oncology Laboratories
West Chester, PA (USA)

For information on our services, including the PrevistageTM GCC Colorectal Cancer Staging Test offered by DiagnoCure Oncology Laboratories, please contact us at:

• customercare@diagnocure.com
• (877) 701-9007

Bladder Cancer Test (formerly ImmunoCyt™/uCyt+™)

Diagnocure entered into a product divestment agreement for ImmunoCyt™/uCyt+™ with U.S.-based Scimedx Corporation.

More on Scimedx